Imagine trying to move a delicate living organ or a batch of living cells across the world without freezing them, which would kill them. It is like trying to move a tiny, fragile greenhouse that must keep its exact temperature and air mix at all times. This technology acts as a portable, high-tech incubator that keeps these living medicines alive and healthy during travel.
Many advanced therapy medicinal products cannot be frozen and require strict environmental controls. Current transport vessels are inadequate, preventing the global delivery of live cell-based treatments to patients.
A self-sustaining incubator (Cellbox Go/AT) that controls temperature, CO2, and oxygen levels for the safe transport of clinical-grade biological materials.
If you are an ATMP manufacturer dealing with fragile cells that cannot be cryopreserved — this project developed the Cellbox Go/AT that ensures product safety and function during global transport. This allows you to reach patients throughout the EU and globally without risking cell death.
If you are a specialized bio-courier dealing with the lack of clinical-grade transport vessels — this project developed an IATA-approved flight solution. This enables the shipment of sensitive biological materials that must not be frozen.
If you are a regenerative medicine clinic dealing with the risk of biological structure changes during cell delivery — this project developed a self-sustaining incubator. This maintains high quality and reduces the risk of losing valuable cells during the final delivery to the patient.
Based on available project data, specific pricing or cost details for the units are not provided.
Yes, the project is developing the Cellbox Go/AT to establish a new value chain for global transport of ATMPs, including IATA-approved versions for air transport.
The technology was developed in cooperation with the Fraunhofer Institute, though specific licensing terms are not detailed in the provided data.
The project is developing regulatorily compliant software, data management, and packaging solutions compatible with international air transport regulations.
The project period runs from 2023-10-01 to 2025-09-30 to develop the Cellbox AT version.
The project is led by a single German SME, Cellbox Solutions, which indicates a highly streamlined, industry-driven approach. With a 100% industry ratio and a previous partnership with the Fraunhofer Institute, the consortium is focused on commercial execution rather than academic research.
Contact Cellbox Solutions in Germany
Contact us to explore integration of Cellbox AT into your ATMP supply chain.
